Biologics in foot and ankle surgery.
This article is another review of clinical application of the use of bone morphogenetic proteins, specifically rhBMP2 Infuse Bonegraft, in the treatment of both acute and chronic fracture and fusion situations. Overall experience is reported with particular detail to the use of biologics in the treatment of problems involving the tibia, foot, and ankle.
Central States Ortho Specialists Inc, 6585 South Yale, Suite 200, Tulsa, OK 94136-8320, USA. bhawkins@csosortho.com
Bryan J
BJ
Hawkins
D000293:Adolescent; D000328:Adult; D000368:Aged; D016512:Ankle Injuries / Q000601:surgery*; D001174:Arthrodesis; D055396:Bone Morphogenetic Protein 2; D019485:Bone Morphogenetic Proteins / Q000627:therapeutic use*; D005260:Female; D005360:Fibula / Q000293:injuries*; D017102:Fracture Healing / Q000187:drug effects* / Q000502:physiology*; D050723:Fractures, Bone / Q000601:surgery*; D018460:Fractures, Comminuted / Q000601:surgery; D006801:Humans; D008297:Male; D008875:Middle Aged; D011446:Prospective Studies; D011994:Recombinant Proteins / Q000627:therapeutic use*; D012086:Reoperation; D013978:Tibial Fractures / Q000601:surgery*; D016212:Transforming Growth Factor beta / Q000627:therapeutic use*; D055815:Young Adult
D055396:Bone Morphogenetic Protein 2; D019485:Bone Morphogenetic Proteins; D011994:Recombinant Proteins; D016212:Transforming Growth Factor beta; C499469:recombinant human bone morphogenetic protein-2